Potential applications of polymers in the delivery of drugs to the central nervous system

Colloids and Surfaces B: Biointerfaces

Volumn 16, Issue 1-4, 1999, Pages 321-330

  Miller, Donald W ^a   Kabanov, Alexander V ^a  

^a 986025 Nebraska Medical Center ^*  (United States)

Author keywords

Blood brain barriers; Blood cerebral spinal fluid barriers; Central nervous system; Polymeric drug delivery systems

Indexed keywords

CYCLOSPORIN A; DRUG CARRIER; GLYCOPROTEIN P; MANNITOL; MULTIDRUG RESISTANCE PROTEIN; RHODAMINE 123;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; CENTRAL NERVOUS SYSTEM; DRUG DELIVERY SYSTEM; MICELLE; NONHUMAN; PRIORITY JOURNAL;

BLOOD; CONTROLLED DRUG DELIVERY; NEUROLOGY;

POLYMERIC DRUG DELIVERY SYSTEMS;

POLYMERS;

EID: 0032846131     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0927-7765(99)00082-X     Document Type: Article

References (52)

1. Yokoyama M. Crit. Rev. Ther. Drug Carrier Syst. 9:1992;213.
2. Lasic D.D. Nature. 355:1992;279.
3. Kararli T.T., Gupta V.W. J. Pharm. Sci. 81:1992;483.
4. Lalor C.B., Flynn G.L., Weiner N. J. Pharm. Sci. 84:1995;673.
5. Kato Y., Watanabe K., Nakakura M., Hosokawa T., Hayakawa E., Ito K. Chem. Pharm. Bull. 41:1993;599.
6. Takino T., Nakajima C., Takakura Y., Sezaki H., Hashida M. J. Drug Target. 1:1993;117.
7. Zhang X., Burt H.M., Mangold G., Dexter D., Von Hoff D., Mayer L., Hunter W.L. Anticancer Drugs. 8:1997;696.
8. Spatz H. Arch. Phsychiat. Nervenheilk. 101:1934;191.
9. Bradbury M.W. Newalt E.A. Implications of the Blood-Brain Barrier and Its Manipulation. 1:1989;119 Plenum, , p, NY.
10. Reese T.S., Karnovsky M.J. Cell Biol. 34:1967;207.
11. Brightman M.W., Reese T.S. Cell Biol. 40:1969;648.
12. Audus K.L., Chikhale P.J., Miller D.W., Thompson S.E., Borchardt R.T. Adv. Drug Res. 23:1992;3.
13. Miller D.W., Kato A., Ng K-Y., Chikhale E.G., Borchardt R.T. Taylor M.D., Amidon G.L. Peptide Based Drug Design: Controlling Transport and Metabolism. 1995;475 American Chemical Society, Washington DC.
14. Vorbrodt A.W. Prog. Histochem. 18:1988;1.
15. Johanson C.E. Newalt E.A. Implications of the Blood-Brain Barrier and Its Manipulation. 1:1989;223 Plenum, NY.
16. Toth I. J. Drug Target. 2:1994;217.
17. Ford H., Siddiqui M.A., Driscoll J.S., Marquez V.E., Kelley J.A., Mitsuya H., Shirasaka T. J. Med. Chem. 38:1995;1189.
18. Driscoll J.S., Siddiqui M.A., Ford H., Kelley J.A., Roth J.S., Hitsuya H., Tanaka M., Marquez V.E. J. Med. Chem. 39:1996;1619.
19. Suzuki F., Hayashi H., Ito S., Hayaishi O. Biochim. Biophys. Acta. 917:1987;224.
20. Greene D.L., Hau V.S., Abbruscato T.J., Bartosz H., Misicka A., Lipkowski A.W., Hom S., Gillespie T.J., Hruby V.J., Davis T.P. J. Pharmacol. Exp. Ther. 277:1996;1366.
21. Patel D., McKinley B.D., Davis T.P., Porreca F., Yamamura H.I., Hruby V.J. Bioconjug. Chem. 8:1997;434.
22. Anderson W.R., Simpkins J.W., Brewster M.E., Bodor N. Drug Des. Deliv. 2:1988;287.
23. Bodor N., Prokai L., Wu W.M., Farag H., Jonalagadda S., Kawamura M., Simpkins J. Science. 257:1992;1698.
24. Brewster M.E., Raghaven K., Pop E., Bodor N. Antimicrob. Agents Chemother. 38:1994;817.
25. Burton P.S., Conradi R.A., Ho N.F., Hilgers A.R., Borchardt R.T. J. Pharm. Sci. 85:1996;1336.
26. Takada Y., Vistica D.T., Greig N.H., Purdon D., Rapoport S.I., Smith Q.R. Canc. Res. 52:1992;2191.
27. Wu D., Boado R.J., Pardridge W.M. J. Pharmacol. Exp. Ther. 276:1996;206.
28. Wu D., Pardridge W.M. Drug Metab. Dispos. 26:1998;937.
29. Fukuta M., Okada H., Iinuma S., Yanai S., Toguchi H. Pharm. Res. 11:1994;1681.
30. Wu D., Yang J., Pardridge W.M. J. Clin. Invest. 100:1997;1804.
31. Schinkel A.H., Smit J.J.M., van Tellingem O., Beijnen J.H., Wagenaar E., van Deemter L., Mol C.A.A.M., van der Valk M.A., Robanu-Maandag E.C., Riele H.P.J., Berns A.J.M., Borst P. Cell. 77:1994;491.
32. Fontaine M., Elmquist W.F., Miller D.W. Life Sci. 59:1996;1521.
33. Huai-Yun H., Secrest D.T., Mark K.S., Carney D., Brandquist C., Elmquist W.F., Miller D.W. Biochem. Biophys. Res. Comm. 243:1998;816.
34. Seetharaman S., Barrand M.A., Maskell L., Scheper R.J. J. Neurochem. 70:1998;1151.
35. Regina A., Koman A., Piciotti M., Hafny B.E., Center M.S., Bergmann R., Couraud P.-O., Roux F. J. Neurochem. 71:1998;705.
36. Banks W.A., Kastin A.J., Fischman A.J., Coy D.H., Strauss S.L. Am. J. Physiol. 251:1986;E477.
37. Rao V.V., Dahlheimer J.L., Bardgett M.E., Snyder A.Z., Finch R.A., Sartorelli A.C., Piwnica-Worms D. Proc. Natl. Acad. Sci. USA. 96:1999;3900.
38. Yokoyama M., Miyauchi M., Yomada N. et al. Canc. Res. 51:1991;3229.
39. Batrakova E.V., Dorodnych T.Y., Klinskii E.Y. et al. Br. J. Canc. 74:1996;1545.
40. Kwon G.S., Kataoka K Adv. Drug Delivery Rev. 16:1995;295.
41. Huwyler J., Wu D., Pardridge W.M. Proc. Natl. Acad. Sci. 93:1996;14164.
42. Pardridge W.M., Wu D., Sakane T. Pharm. Res. 15:1998;576.
43. Alakhov V.Y., Kabanov A.V. Exp. Opin. Invest. Drugs. 7:1998;1453.
44. Pratten M.K., Lioyd J.B., Horpel G. et al. Makromol. Chem. 186:1985;725.
45. Kabanov A.V., Slepnev V.I., Kuznetsova L.E., Batrikova E.V., Alakhov V.Y., Melik-Nubarov N.S., Sveshnikov P.G., Kabanov V.A. Biochem. Int. 26:1992;1035.
46. Miller D.W., Keller B.T., Borchardt R.T. J. Cell. Physiol. 161:1994;333.
47. Batrakova E.V., Han H.-Y., Miller D.W., Kabanov A.V. Pharm. Res. 15:1998;1525.
48. Kabanov A.V., Batrakova E.V., Melik-Nubarov N.S., Fedoseev N.A., Dorodnich T.Y., Alakhov V.Y., Chekhonin V.P., Nazarova I.R., Kabanov V.A. J. Contr. Rel. 22:1992;141.
49. Miller D.W., Batrakova E.V., Waltner T.O., Alakhov V.Y., Kabanov A.V. Bioconj. Chem. 8:1997;649.
50. Batrakova E.V., Han H-Y., Alakhov V.Y., Miller D.W., Kabanov A.V. Pharm. Res. 15:1998;850.
51. Venne A., Li S., Mandeville R., Kabanov A.V., Alakhov V.Y. Canc. Res. 56:1996;3626.
52. Nerurkar M.M., Burton P.S., Borchardt R.T. Pharm. Res. 13:1996;528.